Optimal Alignments for Designing Urban Transport Systems: Application to Seville

The achievement of some of the Sustainable Development Goals (SDGs) from the recent 2030 Agenda for Sustainable Development has drawn the attention of many countries towards urban transport networks. Mathematical modeling constitutes an analytical tool for the formal description of a transportation system whereby it facilitates the introduction of variables and the definition of objectives to be optimized. One of the stages of the methodology followed in the design of urban transit systems starts with the determination of corridors to optimize the population covered by the system whilst taking into account the mobility patterns of potential users and the time saved when the public network is used instead of private means of transport. Since the capture of users occurs at stations, it seems reasonable to consider an extensive and homogeneous set of candidate sites evaluated according to the parameters considered (such as pedestrian population captured and destination preferences) and to select subsets of stations so that alignments can take place. The application of optimization procedures that decide the sequence of nodes composing the alignment can produce zigzagging corridors, which are less appropriate for the design of a single line. The main aim of this work is to include a new criterion to avoid the zigzag effect when the alignment is about to be determined. For this purpose, a curvature concept for polygonal lines is introduced, and its performance is analyzed when criteria of maximizing coverage and minimizing curvature are combined in the same design algorithm. The results show the application of the mathematical model presented for a real case in the city of Seville in Spain.Ministerio de Economía y Competitividad MTM2015-67706-

Experimental techniques and numerical models to detect pollutant emission in the transport sector

25th International Conference on Urban Transport and the Environment, Urban Transport 2019; Aveiro; Portugal; 25 June 2019 through 27 June 2019; Code 155807In recent years, the growth of fossil fuel use and greenhouse gases emissions (GHGs) has been promoted by the population increase and development of the industry sector. Due to the increasing attention towards the effects of climate changes on quality of life, recent researches on pollutant formation processes have been developed in different sectors, especially in transportation. The last emission standards on pollutants impose limits on the dimensions and on the particle number of the particulate matter emissions, because of the highly dangerous effect on human health. To fight high concentrations of particulate matter (PM) emissions, a wide number of studies are addressed towards the definition of the most important parameters in effective production of particulate matter, especially in spark ignition engines. Physical processes such as mixture formation, engine operating parameters and fuel chemical properties strongly affect the soot formation in gasoline engines. The heat transfer process between the piston hot surface and the fuel gasoline during the post-injection phase is a key aspect of soot emissions for an engine. This paper is devoted to analyzing the fundamental parameters that are responsible for pollutant formation in the transport sector and the actual experimental and numerical techniques used to predict the environmental impact of engines

EVALUATION OF IMPACT OF ELEVATED TEMPERATURES ON YOUNG’S MODULUS OF GLT BEAMS

The influence of elevated temperatures on mechanical behavior of glued laminated timber beams is examined on the basis of tensile tests. Dog bone samples prepared from beams exposed to fire of variable duration were categorized with respect to the type and position of the failure crack, type and number of discontinuities such as knots, and the level of browning. The acquired experimental results suggest that the wood variability and the effect of growth discontinuities are probably more significant than the effect of elevated temperatures. To support this conclusion, further study is currently under way, exploring samples from the second series of the fire tests

Alternative Fuels for Combined Cycle Power Plants: An Analysis of Options for a Location in India

The Sustainable Development Goals 2030 Agenda of United Nations raises the need of clean and a ordable energy. In the pathway for more e cient and environmentally friendly solutions, new alternative power technologies and energy sources are developed. Among these, the use of syngas fuels for electricity generation can be a viable alternative in areas with high biomass or coal availability. This paper presents the energy, environmental and economic analyses of a modern combined cycle plant with the aim to evaluate the potential for a combined power plant running with alternative fuels. The goal is to identify the optimal design in terms of operating conditions and its environmental impact. Two possible configurations are investigated in the power plant presented: with the possibility to export or not export steam. An economic analysis is proposed to assess the plant feasibility. The e ect of the di erent components in its performance is assessed. The impact of using four di erent syngases as fuel is evaluated and compared with the natural gas fuelled power cycle. The results show that a better e ciency is obtained for the syngas 1 (up to 54%), in respect to the others. Concerning pollutant emissions, the syngas with a GHG impact and lower carbon dioxide (CO2) percentage is syngas 2

Lertal®, a multicomponent nutraceutical, could reduce the use of antihistamines in children with allergic rhinoconjunctivitis

Antihistamines are the cornerstone treatment of allergic rhinitis (AR). To quantify the antihistaminic consume is particularly relevant in clinical practice, since a remarkable use is usually associated with severe symptoms. The aim of the study was to measure the use of antihistamines in two groups of children suffering from AR. The first group took a course of a nutraceutical (Lertal®) before the observation (active group, AG); a second one was considered as control (control group, CG). Both groups took antihistamines on demand. The children were visited at baseline and after 1 year. The number of days of antihistaminic use was the primary outcome. Children in AG had a significant reduced number of antihistamines use in comparison with CG (p=0.008). In conclusion, the current study showed that a course with a multicomponent nutraceutical could reduce the use of symptomatic antihistamines in children with allergic rhinoconjunctivitis

Respiratory infections in allergic children: the preventive role of a multicomponent nutraceutical

Allergic children with respiratory infections (RI) are a demanding challenge for the paediatrician. Antibiotic prescription represents a critical problem, mainly concerning the growing issue of resistance. To prevent RI would be therefore a goal in clinical practice. In this regard, modulation of immune system may have a critical role. e aim of the present study was to measure the number of respiratory infections and the use of antibiotics in two groups of children su ering from allergic rhinoconjunctivitis. e rst group took a course of a nutraceutical (Lertal®) before the observation (active group, AG); a second one was considered as control (control group, CG). e children were visited at baseline and after 1 year. e number of RI and of antibiotic courses was the primary outcomes. Children in AG reported a signi cant reduced number of RI and of antibiotic course in comparison with CG (p=0.01 and 0.002 respectively). In conclusion, the current study showed that a course with a multicomponent nutraceutical could reduce the number of respiratory infections and consequently the use of antibiotics in children with allergic rhinoconjunctivitis. (www.actabiomedica.it

Consensus communication strategies to improve doctor-patient relationship in paediatric severe asthma

Background: Asthma is a chronic inflammatory disease that is very common among youth worldwide. The burden of this illness is very high not only considering financial costs but also on emotional and social functioning. Guidelines and many researches recommend to develop a good communication between physicians and children/caregiver and their parents. Nevertheless, a previous Italian project showed some criticalities in paediatric severe asthma management. The consensus gathered together experts in paediatric asthma management, experts in narrative medicine and patient associations with the aim of identify simple recommendation to improve communication strategies. Methods: Participants to the consensus received the results of the project and a selection of narratives two weeks before the meeting. The meeting was structured in plenary session and in three working groups discussing respectively about communication strategies with children, adolescents and parents. The task of each working group was to identify the most effective (DO) and least effective practices (DON' T) for 5 phases of the visit: welcome, comprehension of the context, emotions management, duration and end of the visit and endurance of the relationship. Results: Participants agreed that good relationships translate into positive outcomes and reached consensus on communication strategies to implement in the different phase of relationships. Conclusions: The future challenges identified by the participants are the dissemination of this Consensus document and the implementation of effective communication strategies to improve the management of pediatric asthma

Italian intersociety consensus on management of long covid in children

Background: Two sequelae of pediatric COVID-19 have been identified, the multisystem inflammatory syndrome in children (MIS-C) and the long COVID. Long COVID is much less precisely defined and includes all the persistent or new clinical manifestations evidenced in subjects previously infected by SARS-CoV-2 beyond the period of the acute infection and that cannot be explained by an alternative diagnosis. In this Intersociety Consensus, present knowledge on pediatric long COVID as well as how to identify and manage children with long COVID are discussed. Main findings: Although the true prevalence of long COVID in pediatrics is not exactly determined, it seems appropriate to recommend evaluating the presence of symptoms suggestive of long COVID near the end of the acute phase of the disease, between 4 and 12 weeks from this. Long COVID in children and adolescents should be suspected in presence of persistent headache and fatigue, sleep disturbance, difficulty in concentrating, abdominal pain, myalgia or arthralgia. Persistent chest pain, stomach pain, diarrhea, heart palpitations, and skin lesions should be considered as possible symptoms of long COVID. It is recommended that the primary care pediatrician visits all subjects with a suspected or a proven diagnosis of SARS-CoV-2 infection after 4 weeks to check for the presence of symptoms of previously unknown disease. In any case, a further check-up by the primary care pediatrician should be scheduled 3 months after the diagnosis of SARS-CoV-2 infection to confirm normality or to address emerging problems. The subjects who present symptoms of any organic problem must undergo a thorough evaluation of the same, with a possible request for clinical, laboratory and / or radiological in-depth analysis in case of need. Children and adolescents with clear symptoms of mental stress will need to be followed up by existing local services for problems of this type. Conclusions: Pediatric long COVID is a relevant problem that involve a considerable proportion of children and adolescents. Prognosis of these cases is generally good as in most of them symptoms disappear spontaneously. The few children with significant medical problems should be early identified after the acute phase of the infection and adequately managed to assure complete resolution. A relevant psychological support for all the children during COVID-19 pandemic must be organized by health authorities and government that have to treat this as a public health issue

Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement

The fast diffusion of the SARS-CoV-2 pandemic have called for an equally rapid evolution of the therapeutic options.The Human recombinant monoclonal antibodies (mAbs) have recently been approved by the Food and Drug Administration (FDA) and by the Italian Medicines Agency (AIFA) in subjects aged ≥12 with SARS-CoV-2 infection and specific risk factors.Currently the indications are specific for the use of two different mAbs combination: Bamlanivimab+Etesevimab (produced by Eli Lilly) and Casirivimab+Imdevimab (produced by Regeneron).These drugs have shown favorable effects in adult patients in the initial phase of infection, whereas to date few data are available on their use in children.AIFA criteria derived from the existing literature which reports an increased risk of severe COVID-19 in children with comorbidities. However, the studies analyzing the determinants for progression to severe disease are mainly monocentric, with limited numbers and reporting mostly generic risk categories.Thus, the Italian Society of Pediatrics invited its affiliated Scientific Societies to produce a Consensus document based on the revision of the criteria proposed by AIFA in light of the most recent literature and experts' agreement.This Consensus tries to detail which patients actually have the risk to develop severe disease, analyzing the most common comorbidities in children, in order to detail the indications for mAbs administration and to guide the clinicians in identifying eligible patients

An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children

Since the beginning of 2020, a remarkably low incidence of respiratory virus hospitalizations has been reported worldwide. We prospectively evaluated 587 children, aged <12 years, admitted for respiratory tract infections from 1 September 2021 to 15 March 2022 in four Italian pediatric hospitals to assess the burden of respiratory viruses during the COVID-19 pandemic in Italy. At admission, a Clinical Respiratory Score was assigned and nasopharyngeal or nasal washing samples were collected and tested for respiratory viruses. Total admissions increased from the second half of October 2021 to the first half of December 2021 with a peak in early November 2021. The respiratory syncytial virus (RSV) incidence curve coincided with the total hospitalizations curve, occurred earlier than in the pre-pandemic years, and showed an opposite trend with respect to the incidence rate of SARS-CoV-2. Our results demonstrated an early peak in pediatric hospitalizations for RSV. SARS-CoV-2 may exhibit a competitive pressure on other respiratory viruses, most notably RSV